Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Lage

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Electrophoresis|July 23, 2003
Study of the development of chemoresistance in melanoma cell lines using proteome analysisPranav Sinha, Julia Poland, Sandro Kohl, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 12, 2005
Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patientsPaweł Surowiak, Verena Materna, Katarzyna Kłak, et al.
Cancer Letters|June 23, 2005
Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancersPaweł Surowiak, Verena Materna, Carsten Denkert, et al.
Oligonucleotides|September 19, 2006
Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cellsAxel Priebsch, Franziska Rompe, Holger Tönnies, et al.
Oncology Reports|February 19, 2014
Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-upPiotr Donizy, Grazyna Pietrzyk, Agnieszka Halon, et al.
Bioorganic & Medicinal Chemistry|July 6, 2010
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulatorsClaudius Coburger, Jörg Wollmann, Martin Krug, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 9, 2016
Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death inductionMariana Alves Reis, Omar Bauomy Ahmed, Gabriella Spengler, et al.
Journal of Natural Products|April 20, 2017
Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in CancerMariana A Reis, Omar B Ahmed, Gabriella Spengler, et al.
Anticancer Research|January 12, 2007
CD46 expression is indicative of shorter revival-free survival for ovarian cancer patientsPawel Surowiak, Verena Materna, Adam Maciejczyk, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2007
Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patientsVerena Materna, Paweł Surowiak, Irina Kaplenko, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Electrophoresis|July 23, 2003
Study of the development of chemoresistance in melanoma cell lines using proteome analysisPranav Sinha, Julia Poland, Sandro Kohl, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 12, 2005
Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patientsPaweł Surowiak, Verena Materna, Katarzyna Kłak, et al.
Cancer Letters|June 23, 2005
Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancersPaweł Surowiak, Verena Materna, Carsten Denkert, et al.
Oligonucleotides|September 19, 2006
Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cellsAxel Priebsch, Franziska Rompe, Holger Tönnies, et al.
Oncology Reports|February 19, 2014
Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-upPiotr Donizy, Grazyna Pietrzyk, Agnieszka Halon, et al.
Bioorganic & Medicinal Chemistry|July 6, 2010
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulatorsClaudius Coburger, Jörg Wollmann, Martin Krug, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 9, 2016
Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death inductionMariana Alves Reis, Omar Bauomy Ahmed, Gabriella Spengler, et al.
Journal of Natural Products|April 20, 2017
Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in CancerMariana A Reis, Omar B Ahmed, Gabriella Spengler, et al.
Anticancer Research|January 12, 2007
CD46 expression is indicative of shorter revival-free survival for ovarian cancer patientsPawel Surowiak, Verena Materna, Adam Maciejczyk, et al.
Virchows Archiv : an International Journal of Pathology|January 12, 2007
Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patientsVerena Materna, Paweł Surowiak, Irina Kaplenko, et al.
Pageof 13